Market Overview:
The global preventive vaccines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising incidence of infectious diseases, increasing awareness about preventive vaccines, and technological advancements in the field of preventive vaccines. Based on type, the global preventive vaccines market is segmented into intramuscular injection, nasal spray, and intradermal shot. Intramuscular injection is further sub-segmented into hepatitis B vaccine, diphtheria-tetanus-acellular pertussis (DTaP) vaccine, Haemophilus influenzae type b (Hib) vaccine, human papillomavirus (HPV) vaccine,,meningococcal conjugate vaccine (MCV4), pneumococcal conjugate vaccine (PCV13), and Japanese encephalitis virus (JEV)vaccine. Nasal spray is further sub-segmented into live attenuated influenza virus nasal spray(LAIV), inactivated influenza virus nasal spray(IIV), and recombinant hemagglutinin protein antigen nasal spray(rHA). Intradermal shot is further sub-segmented into hepatitis B surface antigen intradermal test kit.(HBsAg IDTKIT).
Product Definition:
Preventive vaccines are administered to people who have not yet been infected with a pathogen. The purpose of preventive vaccines is to protect the individual from becoming infected and developing disease. Preventive vaccines are important because they can reduce the incidence of disease in the population and prevent outbreaks.
Intramuscular Injection:
Intramuscular injection is a procedure wherein the vaccine is injected into muscle tissues. The most commonly used muscles are the deltoid, quadriceps, and gastrocnemius.
Nasal Spray:
Nasal spray is a method of immunization by which the vaccine is administered in the nose. The vaccine is then transported to the brain and immune system, where it works like an antigen. Nasal spray has been used for decades as a safe and effective way to administer vaccines to infants and children all over the world.
Application Insights:
The hospital application segment led the global preventive vaccines market in 2017. This can be attributed to factors such as high usage rates of intramuscular injections and preference for immunization at the time of hospital admission. The other application segment includes clinics and hospitals, wherein preventative vaccines are given to patients based on their vaccination history or risk assessment.
The Clinic/Other segment is anticipated to witness a lucrative CAGR over the forecast period owing to increasing government initiatives that support immunization programs against diseases such as chickenpox, typhoid, cholera and measles among others. Furthermore, growing awareness about diseases along with rising incidences of travelers¢â‚¬â„¢ diarrhea is expected fuel demand for these shots in travel clinics across various regions globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the fact that most of the developed countries in this region have a well-established healthcare infrastructure and high awareness levels regarding vaccination programs. Moreover, these regions are home to several multinational companies, which are actively involved in research & development activities for preventive vaccines. These factors will continue to drive regional growth during the forecast period as well.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives for mass immunization drives and improving healthcare facilities across developing economies such as India and China. Furthermore, rising incidences of infectious diseases due to growing population along with rapid urbanization will also serve as key drivers for regional growth during this period (Henceforth referred as Asia Pacific).
Growth Factors:
- Increasing incidence of infectious diseases: The global prevalence of infectious diseases is increasing at an alarming rate. This is primarily due to the increase in international travel and trade, rapid urbanization, and changes in lifestyle and eating habits. This has led to a rise in the demand for preventive vaccines.
- Growing awareness about preventive vaccines: There is a growing awareness among people about the benefits of preventive vaccines. This has led to an increase in the demand for these vaccines across the world.
- Technological advancements: The vaccine industry is witnessing rapid technological advancements, which are helping manufacturers develop better and more effective preventive vaccines. This is leading to an increase in demand for these products worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Preventive Vaccines Market Research Report
By Type
Intramuscular Injection, Nasal Spray, Intradermal Shot
By Application
Hospital, Clinic, Other
By Companies
Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline, Serum Institute of India
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Preventive Vaccines Market Report Segments:
The global Preventive Vaccines market is segmented on the basis of:
Types
Intramuscular Injection, Nasal Spray, Intradermal Shot
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- AstraZeneca
- CSL Ltd
- Abbott
- GlaxoSmithKline
- Serum Institute of India
Highlights of The Preventive Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intramuscular Injection
- Nasal Spray
- Intradermal Shot
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preventive Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preventive vaccines are vaccines that are designed to prevent disease in people before it occurs. They can be used to protect against a wide range of diseases, including some types of cancer.
Some of the major players in the preventive vaccines market are Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline, Serum Institute of India.
The preventive vaccines market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Preventive Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Preventive Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Preventive Vaccines Market - Supply Chain
4.5. Global Preventive Vaccines Market Forecast
4.5.1. Preventive Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Preventive Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Preventive Vaccines Market Absolute $ Opportunity
5. Global Preventive Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Preventive Vaccines Market Size and Volume Forecast by Type
5.3.1. Intramuscular Injection
5.3.2. Nasal Spray
5.3.3. Intradermal Shot
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Preventive Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Preventive Vaccines Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Preventive Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Preventive Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Preventive Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Preventive Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Preventive Vaccines Demand Share Forecast, 2019-2026
9. North America Preventive Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Preventive Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Preventive Vaccines Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Preventive Vaccines Market Size and Volume Forecast by Type
9.7.1. Intramuscular Injection
9.7.2. Nasal Spray
9.7.3. Intradermal Shot
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Preventive Vaccines Demand Share Forecast, 2019-2026
10. Latin America Preventive Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Preventive Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Preventive Vaccines Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Preventive Vaccines Market Size and Volume Forecast by Type
10.7.1. Intramuscular Injection
10.7.2. Nasal Spray
10.7.3. Intradermal Shot
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Preventive Vaccines Demand Share Forecast, 2019-2026
11. Europe Preventive Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Preventive Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Preventive Vaccines Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Preventive Vaccines Market Size and Volume Forecast by Type
11.7.1. Intramuscular Injection
11.7.2. Nasal Spray
11.7.3. Intradermal Shot
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projection by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Preventive Vaccines Demand Share, 2019-2026
12. Asia Pacific Preventive Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Preventive Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Preventive Vaccines Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Preventive Vaccines Market Size and Volume Forecast by Type
12.7.1. Intramuscular Injection
12.7.2. Nasal Spray
12.7.3. Intradermal Shot
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Preventive Vaccines Demand Share, 2019-2026
13. Middle East & Africa Preventive Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Preventive Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Preventive Vaccines Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Preventive Vaccines Market Size and Volume Forecast by Type
13.7.1. Intramuscular Injection
13.7.2. Nasal Spray
13.7.3. Intradermal Shot
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Preventive Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Preventive Vaccines Market: Market Share Analysis
14.2. Preventive Vaccines Distributors and Customers
14.3. Preventive Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sanofi
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AstraZeneca
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CSL Ltd
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GlaxoSmithKline
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Serum Institute of India
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook